Table: begin end state 1 5 non-cytoplasmic 6 22 transmembrane 23 28 cytoplasmic 29 53 transmembrane 54 59 non-cytoplasmic 60 79 transmembrane 80 101 cytoplasmic 102 132 transmembrane 133 138 non-cytoplasmic 139 158 transmembrane 159 177 cytoplasmic 178 198 transmembrane 199 229 non-cytoplasmic 230 252 transmembrane 253 262 cytoplasmic 263 285 transmembrane 286 304 non-cytoplasmic 305 325 transmembrane 326 344 cytoplasmic 345 368 transmembrane 369 386 non-cytoplasmic 387 410 transmembrane 411 421 cytoplasmic 422 444 transmembrane 445 447 non-cytoplasmic
Input: >AO353_25205 MTPTYSLLTLGASILLIVVLIGKFRVHPFLSLIAASLLVGIGTGMAPTAIVSAFEKGMGS TLGFLAGIIGLGSILGKLLEESGGAKRIATTLLRVLGEKNASWAMMLVGFIAGIPVFFEV GFVLLIPLIYVVARQTRINVLYLGVPLAISLMVVHCILPPHPAATAITGMLNADIGKVIL YGLIVGLPTAVIAGPIWVRLTCTREAPEGQAQFLAARSEAVIDDSKAPSFGIAMVTVLLP LALMVGKTLAAPLLTKGSMTLEWVSFIGNPLIALALSICFAYWSLGLRRGLGMGALLNLT NRCFPPLAGILLIIGAGGAFNDMLVGSGIGKALADVLGQSQINPIILAWLIAGLMHFAVG SATVAMISTAGMVLPILGQHPEYSPEILVIAIGAGAIGWTHVTDSAFWVVKEYLGIPLSE AIKKFTGATVLASSAALVFTLILSRFV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server